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Objective: to evaluate the efficacy of quality of life 
questionnaires St. George Respiratory Questionnaire and 
Chronic Obstructive Pulmonary Disease Assessment Test in 
patients with chronic obstructive pulmonary disease based on 
correlation and agreement analyses, and identify the most 
effective tool to assess their quality of life. Method: cross-
sectional cohort study with patients hospitalized in a Spanish 
hospital for exacerbation of chronic obstructive pulmonary 
disease. Health-related quality of life was assessed with 
both questionnaires. The correlation and the agreement 
between the questionnaires were analyzed, as well as the 
internal consistency. Associations were established between 
the clinical variables and the results of the questionnaire. 
Results: one hundred and fifty-six patients participated in the 
study. The scales had a correlation and agreement between 
them and high internal consistency. A higher sensitivity of 
the Chronic Obstructive Pulmonary Disease Assessment Test 
was observed for the presence of cough and expectoration.  
Conclusion: the questionnaires have similar reliability and 
validity to measure the quality of life in patients with acute 
chronic obstructive pulmonary disease, and the Chronic 
Obstructive Pulmonary Disease Assessment Test is more 
sensitive to detect cough and expectoration and requires a 
shorter time to be completed.
Descriptors: Quality of Life; Pulmonary Disease Chronic 
Obstructive; Lung Diseases, Obstructive; Hospital Care; 
Nursing Assessment; Lung Disease.
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Introduction
Chronic obstructive pulmonary disease (COPD) is 
a common disease and 80 million people suffer from 
the severe or moderate form of this disease(1-2). COPD 
is an avoidable and treatable disease(1). Its diagnosis 
is established by the presence of persistent respiratory 
symptoms, such as dyspnea, cough and sputum 
production. The test to diagnose COPD is spirometry 
(forced expiratory volume ratio in the first second 
(FEV1)/forced vital capacity (FVC) less than 70 after 
bronchodilation)(1).
Despite being an unknown disease, it is the third 
leading cause of death worldwide in developed countries 
after cardiac and oncological diseases(1-3). Continuous 
reduction in lung function is a result of the progression 
of the disease. This situation worsens during periods 
of exacerbation, which happens once or twice a year. 
The treatment requires hospitalization to control the 
symptoms, in a large number of patients(4), implying a 
high cost for the management of the pathology(5). The 
exacerbations accelerate the continuous reduction of 
lung function, reducing the Health Related Quality of Life 
(HRQL) of patients.
HRQL is the personal evaluation made by an 
individual about the suffering caused by the effects of 
an illness or by the application of a treatment in various 
areas of life, especially the consequences on their 
physical, emotional or social well-being(6).
HRQL in chronic respiratory patients is a good 
indicator of disease severity, being significantly related 
to the frequency of exacerbations(7), and its serial 
assessment can act as an indicator of the onset of an 
exacerbation(8). Moreover, it is a good independent 
predictor of mortality(9).
Therefore, HRQL measurement of chronic respiratory 
patients is part of the routine evaluation of the results 
of therapeutic interventions(8) performed by all health 
professionals, be them physicians, nurses, physiotherapists 
or psychologists, among others, in order to know the 
efficacy of the treatment adopted. Thus, HRQL assessment 
should be multidimensional in order to provide a better 
understanding and monitoring of the severity of the 
disease(10-12) through valid and reliable scales(13). Nursing is 
one of the groups that most use these two scales.
In order to measure HRQL, several questionnaires, 
either generic and specific, have showed to have optimal 
psychometric properties of reliability and validity to be 
used in COPD patients, with specific questionnaires 
being the most sensitive to changes during disease 
progression(8).
Among the specific questionnaires, there are several 
that present reliability, validity, precision, consistency 
and sensitivity to changes, and are widely used to 
evaluate HRQL in patients with respiratory diseases. 
They have been adapted to different languages, but with 
different extensions, accessibility, ease of calculation of 
indices and filling time(14). These characteristics may 
influence the gathering of information, especially if the 
patient needs to complete the questionnaire.
According to the recommendations of the Spanish 
Society of Respiratory Diseases (SEPAR) and international 
research(15), the most used questionnaires are the St. 
George Respiratory Questionnaire (SGRQ) and the 
Chronic Obstructive Pulmonary Disease Assessment 
Test (CAT).  The SGRQ (16) validated in Spanish(17-18) 
is the most used questionnaire in the population with 
respiratory diseases(17,19), and it is also validated for 
administration via telephone call(20). The SGRQ has 50 
items distributed into three categories - symptoms, 
activity, and impact - with 76 weighted responses, and 
requires 10 minutes for completion(17). Each item has 
an empirically derived weight, and a score has to be 
calculated.
The CAT questionnaire, recommended by the 
SEPAR, is aimed at evaluating HRQL in patients with 
a diagnosis of COPD. The instrument had initially 21 
items(21) which were later reduced to 8; a total score is 
obtained from the sum of these items(22).
The SGRQ and the CAT present reliability, validity and 
sensitivity to changes during acute exacerbations(23-25). 
The Cronbach’s alpha of the SGRQ is 0.94 (symptoms: 
0.72, activity: 0.89, impact: 0.89) and of the CAT is 
0.88, and the intraclass correlation coefficient of the 
SGRQ and CAT is 0.9 and 0.8, respectively(22).
A literature review revealed a significant correlation 
between the SGRQ and the CAT in a population with 
a diagnosis of COPD in primary care centers(21-22,26-27). 
Likewise, it was observed that there was a correlation 
between the two scales in the hospital setting in patients 
with stable COPD(23), where there is also a correlation 
between the two questionnaires, although CAT is of 
much faster and easier application.
No studies were found to investigate the best 
questionnaire to evaluate HRQL in the hospital setting 
in patients with exacerbated COPD, as confirmed in the 
Spanish guide to COPD patient care(28). This is one of the 
most important moments to evaluate HRQOL, that is, 
to verify the effectiveness of the treatment provided, as 
well as to administer the help and resources necessary 
to train patients before discharge.
Despite the interest generated by the study of 
HRQOL, there is only consensus in the literature about 
the use of the CAT in non-acute stages(29) and primary 
care centers(22), while no consensus exist on the most 
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appropriate choice to evaluate the HRQOL in hospitalized 
patients with exacerbated condition.
Therefore, the main objective of this study is to 
evaluate the efficacy of the SGRQ and CAT questionnaires 
to evaluate quality of life based on the analysis of their 
correlation and agreement, and to identify which is the 
simplest tool to evaluate the quality of life of hospitalized 
patients with severe exacerbation of COPD.
Method
A cross-sectional study with patients admitted to 
the General University Hospital of Castellón (HGUCS) 
(Spain) was carried out between February 2014 and May 
2016, in which the SGRQ and CAT were applied within 
the first five days of admission.
The study population was patients with exacerbation 
of COPD hospitalized in the HGUCS during the period 
of study. The sample size was 150 patients who had 
been diagnosed with severe COPD exacerbation during 
the 27-month study period, based on the annual mean 
of 229 admitted patients diagnosed with this condition, 
a 95% confidence, and a reposition rate of 22%, as 
based on the literature consulted(30). Patients diagnosed 
with COPD exacerbation (ICD 491.2) were included on 
the basis of a history of smoking (active or previous) 
of at least 20 packs a year, along with the presence 
of obstruction of the airway flow defined as FEV1/FVC 
below 70 after bronchodilation, voluntarily decision to 
participate in the study after receiving explanations 
and after understanding the objective of the study. 
All patients who were unable to communicate due to 
physical or mental disabilities, terminal patients with life 
expectancy less than six months according to clinical 
criteria, and patients who met the criteria but rejected 
the invitation to share in the study were excluded.
The variable studied was the HRQOL measured by 
the SGRQ and CAT. Questionnaire St. George Respiratory 
Questionnaire (SGRQ), composed of 50 items divided 
into three dimensions: symptoms of respiratory 
pathology (eight questions); activities that are limited in 
daily life (16 questions); and impact, which refers to the 
social and psychological functioning that can change the 
patient’s lifestyle (26 questions). The sum of the three 
dimensions results in a total score between zero and 
100. Higher scores are indicative of poorer quality of life. 
A calculator is used for calculation(31).
The CAT(13) consists of eight questions related to 
cough, phlegm, chest tightness, breathlessness in 
activities of daily living, activity limitation at home, 
confidence leaving home, sleep, and energy. The score 
interval of each element varies between zero and five, 
with a maximum score of 40(22). According to the total 
CAT scores and the revised literature, patients can be 
classified into the following categories: 1-10 low impact; 
11-20 average impact; 21-30 high impact; 31-40 very 
high impact(13,27).
The control variables were divided into 
sociodemographic variables: sex, age, and schooling; 
clinic variables: dyspnea, through the Medical Research 
Council (MRC)(32), tcough, expectoration, wheezing, 
drowsiness, fever, need to sit, and edema (presented 
as dichotomous variables with yes/no answers), and 
pain through a visual analogue scale (VAS) with a 
score ranging from 0 to 10. The psychological variables 
(anxiety and depression) were studied using the HAD 
questionnaire (33-34) from the Hospital Anxiety and 
Depression Scale and, finally, the level of dependence 
was analyzed using the Barthel index(35).
The data collection procedure was developed 
within the scope of a therapeutic education program 
called Aprendepoc. This is a randomized controlled 
trial with masked data analysis, with no blinding in 
the allocation of participants. With two task groups, 
the Intervention Group (IG) consisted of four group 
educational sessions, telephone follow-up, and delivery 
of informative leaflets; and the Control Group (CG) 
whose intervention was based on conventional care, 
taking into account the standard care provided to all 
patients without being included in the project (without 
group educational sessions, telephone follow-up, or 
delivery of additional documents).
The project was evaluated at admission (from the 
3rd day of hospitalization) and at three months from 
the time of inclusion, although for this investigation 
only the data corresponding to the screening 
(beginning of the study) were used, because the 
sample was homogeneous at the time of recruitment. 
Our results are not affected by the performance of the 
Aprendepoc program.
To recruit patients, once a week, the main 
investigator conducted searched for all patients 
admitted to the hospital who met the inclusion criteria 
using a software tool called “integration”. This search 
allowed to locate the number of the room and the 
number of days of hospital stay. This was the basis 
to select only patients hospitalized for more than two 
days, because the patients had limitations to respond 
to the questionnaires at the day of admission. The 
questionnaires were applied and control variables were 
obtained through a structured interview, followed by 
self-completion of the HAD, Barthel, CAT and SGRQ. 
For the statistical study of sociodemographic variables, 
measures of central tendency were used. The results 
were presented as percentages, mean (x) and standard 
deviation (SD). To determine the correlation between 
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the questionnaires, a factorial analysis of motifs allowed 
to establish eight CAT questions in three dimensions: 
CAT_symptoms, CAT_activity, and CAT_impact. In 
the factorial analysis, a correlation matrix was used 
to correlate the three dimensions created in the CAT 
with the three dimensions of the SGRQ, classifying the 
CAT questions that had a (bilateral) statistical < 0.01 
with some of the SGRQ spheres. In order to test the 
construct created, the Pearson correlation coefficient 
was measured between the means of the newly created 
spheres (CAT_sintomas, CAT_activity, CAT_impact) with 
existing ones (SGRQ_symptoms, SGRQ_activity, SGRQ_
impact). The correlation coefficients were interpreted as 
follows: r < 0.10 (no correlation); r = 0.10 - 0.29 (weak 
correlation); r = 0.30 - 0.49 (moderate correlation); 
and r ≥ 0.50 (strong correlation)(36). To estimate the 
reliability of each of the questionnaires of the sample 
studied, the internal consistency was analyzed through 
the Cronbach’s Alpha. The agreement between the two 
questionnaires was measured through the Bland Altman 
method, which measures the degree of agreement 
between the final result of two questionnaires to see 
whether they behave similarly in the same individuals. 
To perform the calculation, it was considered necessary 
to multiply the CAT score by 0.25 to make it directly 
comparable with the total SGRQ score(27). In order to 
observe the differences between the health status of 
the patient and the total scores of the questionnaires, 
associations were established between the control 
variables and the general score of the questionnaire. Tthe 
Student’s t test was applied in the case of comparisons 
of two groups and Anova in the case of comparisons 
of three or more groups. All p values were reported 
for interpretation, considering statistically significant p 
values < 0.05. The statistical analyses were performed 
in the SPSS v.23 and the Epitat v4.2 for Windows.
The study was approved by the Bioethics and 
Research Committee of the HGUCS and by the 
Deontological Commission of Universitat Jaume I. 
It was carried out following the rules specified in 
the Declaration of Helsinki. The treatment of the 
data was adjusted to the provisions of the Spanish 
Organic Law on Protection of Personal Data, 15/1999, 
of December 13, and of Law 41/2002, of November 
14, on basic regulations about patient autonomy and 
rights and information regarding clinical information 
and documentation. All the study participants signed a 
consent form to participate in the study.
Results
A total of 466 patients were admitted for 
exacerbation of COPD in the HUGC, where 310 were 
excluded due to physical or mental disabilities (n = 
66), terminal condition (n = 85), previous inclusion 
(n = 66), existence of language barrier (n = 9), 
or patients who had the criteria but rejected the 
invitation to share in the study (n = 84). Finally, a 
total of 156 patients met the inclusion criteria, but 
153 (98.1%) were selected because of the presence 
of items left  incomplete in the questionnaire. The 
majority were male, 79.1% (n = 121), with a mean 
age of 73.7 ± 9.8 SD years and primary education 
48.4% (n = 74). In the clinical profile, 43.8% (n = 
63) presented grade III level of dyspnea. The more 
prevalent signs and symptoms were sputum, 75.2% 
(n = 115), followed by cough, 60.8% (n = 93), and 
the need to sleep in the sitting position, 58.2% (n 
= 89). Of the mental health pathologies, the most 
prevalent was depression, 24.2% (n = 37) of the 
probable cases. Regarding the basic activities of daily 
living, 49.0% (n = 75) were severely dependent 
and 20.9% (n = 32) were moderately dependent. 
A summary of the characteristics of the sample is 
presented in Table 1.
Table 1 - Characteristics of the sample according to 
the control variables. Castellón de la Plana, Comunidad 
Valenciana, Spain, 2014, 2015, 2016
Sociodemographic
Age 73.7  ± (DP*9.8)
Sex 
Male 121 (79.1%)
Female 32 (20.9%)
Schooling 
None 26 (17.0%)
Primary school 74 (48.4%)
Secondary school  42 (27.5%)
College 11 (7.2%)
Clinical variables 
Dyspnea (MRC†)
0 2 (1.3%)
I 6 (3.9%)
II 30 (19.6%)
III 67 (43.8%)
IV 43 (28.1%)
Cough 93 (60.8%)
Sputum 115 (75.2%)
Wheezing 73 (47.7%)
Daytime drowsiness 47 (30.7%)
Fever 24 (15.7%)
Edemas 57 (37.3%)
Need to sleep in sitting position 89 (58.2%)
Pain (EVA‡) 1.4 ± (2.3)
(continues...)
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Psychological variables 
Anxiety
No cases 39 (25.5%)
Doubtful case 85 (55.6%)
Probable case 29 (19.0%)
Depression
No cases 37 (24.2%)
Doubtful case 79 (51.6%)
Probable case 37 (24.2%)
Daily life activities
Barthel Index
Total dependence 9 (5.9%)
Severe dependence 75 (49.0%)
Moderate dependence 32 (20.9%)
Mild dependence 8 (5.2%)
Independence 29 (19.0%)
*SD = Standard deviation; †MRC = Medical Research Council; ‡EVA = 
Visual Analog Scale 
A factorial analysis was performed to classify 
the eight questions of the CAT according to the SGRQ 
spheres, which resulted in three spheres in the CAT. 
Thus, the sphere of symptoms of CAT presented a greater 
factorial load in the following items: cough, phlegm and 
oppression; the sphere of CAT_sintomas refered to a 
greater factorial load on the following items: climbing 
stairs and performing household activities; and finally 
the sphere CAT_impact gathered a greater factorial load 
on the items:  confidence leaving home, no problem to 
sleep, and energy. Table 2 shows the correlation matrix 
of the spheres of the two questionnaires.
Table 2 - Matrix of correlations of the questions of the 
Chronic Obstructive Pulmonary Diseases Assessment 
Test with the spheres of the St. George Respiratory 
Questionnaire. Castellón de la Plana, Comunidad 
Valenciana, Spain, 2014, 2015, 2016
SGRQ* 
Symptoms
SGRQ* 
Activity
SGRQ* 
Impact
CAT† cough 0.316‡ 0.095 0.201
CAT† phlegm 0.436‡ 0.187 0.253
CAT† oppression 0.511‡ 0.342 0.380
CAT† climbing stairs 0.458 0.537‡ 0.509
CAT† household activities 0.466 0.486‡ 0.491
CAT† confidence leaving home 0.474 0.461 0.565‡
CAT† sleep 0.528 0.455 0.539‡
CAT† energy 0.504 0.545 0.562‡
*SGRQ = St. George Respiratory Questionnaire; †CAT = Chronic 
Obstructive Pulmonary Diseases Assessment Test; ‡Spheres showing 
correlation p < 0.05 
The Pearson correlation coefficient showed a 
correlation between the new spheres created in the CAT 
and the existing ones of the SGRQ. A strong correlation 
was obtained globally and in the spheres of activity and 
impact, as well as a moderate correlation in the sphere 
of symptoms, as shown in Table 3. It was also observed 
that the two questionnaires presented adequate internal 
consistency in the sample studied, with Cronbach’s 
alpha coefficients of 0.843 for the SGRQ and 0.799 for 
the CAT (Table 3).
Table 3 - Relationship between the spheres created from 
the Chronic Obstructive Pulmonary Disease Assessment 
Test with the spheres of the St George Respiratory 
Questionnaire. Castellón de la Plana, Comunidad 
Valenciana, Spain, 2014, 2015, 2016
Correlation
CAT* symptoms
0.444‡
SGRQ* symptoms
CAT* activity
0.591‡
SGRQ* activity
CAT* impact
0.637‡
SGRQ* impact
Total CAT*
0.628‡
SGRQ† total
Cronbach’s Alpha
Total CAT* 0.799
SGRQ† total 0.843
*CAT = Chronic Obstructive Pulmonary Diseases Assessment Test; 
†SGRQ = St George Respiratory Questionnaire; ‡Spheres showing 
correlation p < 0.01 
The Bland and Altman graph (Figure 1) showed 
that the mean scores of each of the questionnaires 
were within the limits of agreement, confirming the 
agreement between the two questionnaires.
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Figure 1 - Bland and Altman total scores of the St. George 
Respiratoy Questionnaire and Chronic Obstructive 
Pulmonary Diseases Assessment Test. Castellón de la 
Plana, Comunidad Valenciana, Spain, 2014, 2015, 2016
When correlating the global scores of the two 
questionnaires with the clinical variables, all variables 
were statistically significant in the two questionnaires, 
with the exception of cough and sputum, which showed 
statistical significance only in the CAT (p < 0.01), but 
Table 1 - (continuation)
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not in the SGRQ (p = 0.129) and (p = 0.221). Table 4 
shows the results obtained from the correlation between 
the two questionnaires.
Table 4 - Bivariate analysis of the p value obtained 
between the final score of the questionnaire and the 
control variables. Castellón de la Plana, Comunidad 
Valenciana, Spain, 2014, 2015, 2016
CAT* SGRQ†
Dyspnea 0.000‡ 0.000‡
Pain 0.004‡ 0.001
Anxiety 0.000‡ 0.000‡
Depression 0.000‡ 0.000‡
Barthel Index 0.000‡ 0.000‡
Cough 0.000‡ 0.129
Sputum 0.002‡ 0.221 
Wheezing 0.000‡ 0.000‡
Daytime drowsiness 0.001‡ 0.000‡
Fever 0.547 0.232
Edemas 0.047‡ 0.001‡
Need to sleep in sitting position 0.017‡ 0.003‡
*CAT = Chronic Obstructive Pulmonary Diseases Assessment Test; 
†SGRQ = St George Respiratory Questionnaire; ‡Items that presented 
statistical significance.
Discussion
The profile of the study sample was predominantly 
male, aged 73 years, and with primary schoold. 
These characteristics are similar to epidemiological 
studies carried out with COPD patients in the Spanish 
territory (IBEREPOC)(37-38) or international studies(39-40). 
Thus, patients presented a high number of signs and 
symptoms, such as dyspnea, sputum or cough, which 
were related to respiratory infections of exacerbations 
in COPD(41), and the reason for the invitation to share in 
the study.
The CAT questionnaire, as well as the SGRQ, 
presented an internal reliability above 0.7, similar 
to another review(25) on the attributes of the two 
questionnaires. Thus, the existence of correlation 
between the results of the two questionnaires has 
also been valued by several researchers(13) and even 
a correlation of the SGRQ spheres with the total CAT 
result has been reported(26), but no study correlated 
all questions with the SGRQ spheres. There was a 
correlation in the questions attributed to the sphere 
of symptoms, activity or impact of the SGRQ with the 
questions related to these items in the CAT.
Similarly, the results of this study demonstrated 
that HRQOL in COPD patients is associated with 
dyspnea(7,42-46), pain(7), anxiety and depression(7,45,47), 
limitation in the performance of activities( 48), wheezing, 
daytime drowsiness, edema, and the need to sleep 
in the sitting position. It is important to highlight the 
increased sensitivity of the CAT in comparison to the 
SGRQ to detect cough and sputum, while maintaining 
the same sensitivity to detect the remaining variables. 
Thus, the use of the CAT questionnaire is considered 
better in patients with COPD exacerbation in the hospital 
setting, particularly in view of the easier and less time-
consuming completion(26). However, both questionnaires 
were considered sensitive when evaluating HRQOL 
in patients with COPD exacerbation in the hospital 
environment and in patients with stable COPD in the 
primary care setting, as identified in other studies(22).
Finally, another aspect that favors the application 
of the CAT over the SGRQ is the filling time. The SGRG is 
more extensive and presents complex scoring algorithms, 
making its use in clinical practice to become ordinary 
and the repeated evaluation to become inadequate; in 
many cases, it is necessary to help patients complete 
it correctly(49). The mean time to complete the CAT is 
107 seconds, compared to 578 seconds of completion 
required by the SGRQ(23). In hospital environments, the 
use of short questionnaires that facilitate information 
and improve communication between patients and 
health personnel is considered necessary(50-51).
The main limitation of the present study is the 
nature of the data, because the study was not designed 
to verify the effectiveness of the SGRQ and the CAT on 
quality of life in hospitalized patients with severe COPD 
exacerbation. Therefore, data such as retests are missing 
despite the fact that if patients have data in three months, 
this information was rejected because patients do not 
present the same conditions, acting in the education 
program as a confounding factor. Another aspect that 
would be interesting to evaluate is the filling time of each 
of the questionnaires whose data were not studied.
Conclusions
The CAT scores were correlated with the ones of 
the SGRQ, in total, according to spheres and questions. 
Both questionnaires have high internal consistency 
in patients admitted for exacerbation of COPD in 
the hospital setting, and the CAT is more sensitive in 
detecting changes in the HRQOL if the patient has cough 
and sputum only.
Therefore, the CAT is a reliable and accurate tool 
to be used in COPD patients with exacerbation of the 
problem in hospital settings, requiring a shorter time 
than the SGRQ.
The evaluation of the HRQOL in COPD patients is 
a good indicator of severity, and the onset of a new 
exacerbation and mortality. Their routine assessment 
is necessary for better disease monitoring in order to 
www.eerp.usp.br/rlae
7Folch-Ayora A, Macia-Soler L, Cervera-Gasch A.
assess the impact of the disease and the effectiveness of 
the treatment for the performance of activities of daily 
living. The use of CAT will facilitate routine evaluation 
for physicians, nurses, physical therapists, and other 
health professionals in the hospital setting. Admission 
is the time of greatest need for follow-up necessary to 
control the efficacy of the administered treatments, with 
nursing being one of the groups which most uses the 
two questionnaires.
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